Who invested in Vividion Therapeutics

2 rounds we have observed, with the 6 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

BiotechHealthcare

Funding summaryUpdated 26 Oct 2026

$185Mraised across 2 rounds since 2017, from 2 sources

$50MSeries A$135MSeries C

Latest round: Series C, $135MFeb 2021
Step-upi: 2.7×
Investors: 6

See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

20172018201920202021

$50MSeries A$135MSeries C

First round: Series A, $50M
Biggest round: $135M
Between rounds: 4 years

The rounds

Feb 2021
Series C$135M4 new2 returning
Source recordedSEC filing: $135M sold, first sale Feb 2021
Feb 2017
Series A$50M2 new
- ARCH Venture Partners
- Versant Ventures
Reported by FinSMEsSEC filing: $20M sold, first sale Jan 2017

Founders and team

From Vividion Therapeutics's own website and the SEC filings it signed: 15 on the team.

Aleksandra RizoPresident and Chief Executive Officer
Jean BemisChief Operating Officer
Matt PatricelliChief Scientific Officer
Christian RommelDirector
Christine RothDirector
Frank PoschenDirector
Hide OverlayBoard Members
Jeff HatfieldChairman
Olivier Mauroy-BressierDirector
Stefan OelrichDirector
Benjamin L. CravattDirector
Jeffrey HatfieldExecutive Officer, Directori
Patricia L. AllenExecutive Officeri
Richard L. HeymanDirector
Thomas E. DanielDirector

On the board, as filediJakob E. LovenJohn L. ClarkeKristina L. BurowThomas E. Woiwode

Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

Series A2017Series C2021

ARCH Venture Partners

Versant Ventures

RA Capital Management

BlackRock

SoftBankSoftBank Vision Fund

Everyone who backed them

ARCH Venture PartnersVC firm2rounds

Versant VenturesVC firm2rounds

RA Capital ManagementPrivate equity1round

BlackRockAsset manager1round

SoftBankInvestment firm1round

SoftBank Vision FundVC firm1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

These 5 firms list Vividion Therapeutics as a portfolio company on their own websites, but no report of a round names them. They are the firms' own claims, kept apart from the rounds above.

Cardinal PartnersVC firmPer its own site

Nextech InvestPrivate equityPer its own site

Avoro Capital Advi...Private equityPer its own site

Mirae Asset Capital Life ScienceCorporate VCPer its own site

Piedmont Capital InvestmentsVC firmPer its own site

Quick answers about Vividion Therapeutics

Who invested in Vividion Therapeutics?

Vividion Therapeutics's investors include ARCH Venture Partners, Versant Ventures, RA Capital Management, BlackRock and SoftBank, and 1 more on record.